Kivu Biosciences
PrivateLast Round
Series A
Oct 28, 2024
Total Funding Raised
$92M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Kivu Biosciences operates in Healthcare & Life Sciences and is based in San Mateo, California. Its latest recorded funding round was a Series A round in October 2024.
Kivu Biosciences is a biotechnology company developing next-generation antibody-drug conjugates (ADCs) for oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kivu Biosciences Comparables
Compare Kivu Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adcentrx Therapeutics | 88% | |
| Adcendo | 81% | |
| Duality Biotherapeutics Inc | 77% |
For institutional investors. Book with your work email.
Kivu Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Kivu Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brabantse Ontwikkelings Maatschappij | Series A |
| Gimv | Series A |
| M Ventures | Series A |
| HealthCap | Series A |
| Novo Holdings | Series A |
| BioGeneration Ventures | Series A |
| Red Tree Venture Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 31, 2026
Open roles increased to 6, 3x the trailing average.
- Apr 22, 2026
Grew 20% QoQ, from 20 to 24 employees.
For institutional investors. Book with your work email.
Kivu Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kivu Biosciences's valuation, stock price, and market status.
Is Kivu Biosciences a public or private company?
Kivu Biosciences is a private company.
What is the current stock price of Kivu Biosciences?
Kivu Biosciences is a private company, so its shares have no public market price. Caplight tracks Kivu Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kivu Biosciences worth (valuation)?
Valuation information for Kivu Biosciences is not publicly available.
Can I buy Kivu Biosciences stock?
Kivu Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kivu Biosciences's last funding round?
Kivu Biosciences's most recent funding round was Series A on October 28, 2024.
Who are the main investors in Kivu Biosciences?
Key investors in Kivu Biosciences include Novo Holdings.
Will Kivu Biosciences IPO soon?
No public IPO plans have been announced for Kivu Biosciences.
How can I track Kivu Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Kivu Biosciences's shares on secondary markets.